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Abstract
Background: The association of ureterosigmoidostomy with colonic cancer is well established. A
100-fold increased risk of malignancy has been proposed in association with
ureterosigmoidostomy. Characteristically there is a latent period of around 20–30 years before the
occurrence of cancer.
Case presentation: An unusual case of adenocarcinoma of the colon in a 36-year-old patient is
presented. The patient underwent three operations in his infancy for exstrophy but after failure to
close bladder, ureterosigmoidostomy was attempted at the age of 5 years and was converted to an
ileal conduit after 8 months. At the age of 36 years, 30 years following ileal conduit urinary diversion
for exstrophy, he presented in emergency with large bowel obstruction due to adenocarcinoma of
the sigmoid colon.
Conclusion: Patients who undergo urinary diversion for exstrophy may be kept on a regular
follow-up surveillance colonoscopy as most of these young adults may later present with vague
abdominal symptoms which may not be taken seriously until they increase to an extent as to
present with intestinal obstruction as in the present case.
Background
The ureterosigmoidostomy is reported to increase the risk
of malignancy by 100-fold increased risk of malignancy
[1-3]. Characteristically this occurs after a latent period of
20–30 years.
Colonic mucosa has been shown to be at increased risk of
cancer development after prolonged exposure to urine [4],
a term urocolonic tumors was coined by Gittes to explain
this phenomenon [5]. The pathogenesis of these tumors is
not clear. One theory suggests production of nitrite and N-
nitroso compounds from nitrate by the nitrate reducing
bacterial flora in the presence of neutral colonic pH [6].
Although this was challenged by Stribling [7] and
Sahands et al [8], who documented very low levels of N-
nitroso compounds production in the rat models treated
with ascorbic acid as compared to controls, yet both
groups of rats produced urocolonic tumors with same fre-
quency. To answer the question another theory of phago-
cytic activation response was proposed by Dell and
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free radical form uncontrolled inflammatory response,
leading to DNA damage forms the basis of this [10]. We
report here a case of colonic carcinoma occurring 36 years
after uretrosigmoidstomy for exstrophy.
Case presentation
A 36-years-old male presented in emergency department
with constipation for 5 days followed by colicky lower
abdominal pain. There were no vomiting or bowel symp-
toms. He was born with exstrophy and at the age of 5 years
he had underwent an ureterosigmoidostomy, after the
attempts to do a primary closure of the bladder failed.
However, due to continence problems, this was converted
to an ileal conduit eight months later.
On examination he was apyrexial, hemodynamically sta-
ble but looked pale. Long midline and para-median scars
were visible and abdomen was slightly distended. Uros-
tomy bag was present in the right iliac fossa. He had min-
imal tenderness in the left half of the abdomen. Bowel
sounds were audible and digital examination of the rec-
tum was unremarkable. Routine blood tests showed
mildly deranged renal functions (urea of 9.2 mmol/L and
creatinine of 139 mmol/L). Plain abdominal x-ray
showed faecal loading of the left colon. A couple of ene-
mas were prescribed but they failed to relieve the symp-
toms. Over the next two days he gradually deteriorated
with increasing abdominal distension and vomiting.
Repeat abdominal film showed dilated small and large
bowel loops. An unprepared gastrograffin enema was
organized which showed a stricture at the recto-sigmoid
junction. An emergency laparotomy was carried out
which revealed an annular stenosing lesion at the recto-
sigmoid junction with enlarged mesenteric lymph nodes
and dilated proximal bowel. A loop of ileum was adherent
to the surface of colon at the site of tumor. A Hartman's
procedure was carried out and the adherent loop of ileum
was also excised (figure 1). Histopathology showed it to
be Dukes C, poorly differentiated adenocarcinoma of the
sigmoid colon. Proximity of the tumor to the ectopic
urothelium in the sigmoid colon was also demonstrated,
which was the site of previous ureterosigmoidostomy.
Further staging investigations did not show any evidence
of metastasis. The Hartman's procedure was reversed 2
months later and currently he is receiving chemotherapy.
Discussion
Development of a malignant tumor in colon at the age of
36 years without having any familial predisposition to
bowel cancer highlights the possible role of urinary diver-
sion as the predisposing factor. The occurrence of large
bowel tumors after ureterosigmoidostomy (USM) is well
established and backed by several case reports [1]. Some
studies have shown a 100 fold risk of malignancy associ-
ated with USM [2]. A recent study showed 11% risk in
those having USM for 15 years or more [3].
Latent period between USM and the development of the
tumor is another interesting phenomenon. The average
age at diagnosis is reported to be 33 years with a median
interval of 26 years [3]. Due to well established link
between USM and colorectal tumors, other forms of uri-
nary diversion have been tried, ileal conduit formation
being one of them. Following this procedure no case of
urocolonic tumor has been reported till date, although
adenocarcinoma occurring in enteric augmentations is
reported.
Due to the high-risk of malignant tumors following USM
a large number of USM were converted to other forms of
diversions, mostly ileal conduit formation. But the initial
exposure of the colonic mucosa to the urine was enough
to start the chain of events leading to development of
tumors. Strachan and colleagues reported a case of epispa-
dias treated with USM initially and converted to ileal con-
duit 4 years later, and he developed adenocarcinoma at
the site of ureteric stump 24 years later [11]. In the present
case the patient had USM only for 8 months and was con-
verted into ileal conduit, yet after 28 years, he developed
adenocarcinoma of the sigmoid colon. This is so far the
shortest possible exposure of colonic mucosa to urine,
reported in literature leading to the development of
tumor.
Conclusion
The link between USM and colonic carcinogenesis is well
established. The risk is there even with short term expo-
sure of the colonic mucosa to urine and this risk is not
abolished by converting USM to ileal conduits. USM
being a very popular method of urinary diversion, many
general surgeons and colorectal surgeons may be required
to deal with such patients presenting to emergency with
bowel related symptoms later in their life. It is important
to be familiar with the reconstituted anatomy of the pel-
vis, to appreciate the possible risks and to intervene
earlier.
After the relevant literature review, the recommendations
for such cases can be summarized as follows
• Avoid USM as the form of diversion in patients having
benign conditions. Primary closure and staged reconstruc-
tion should be attempted first in cases of exstrophy and in
cases with persistent incontinence use of artificial sphinc-
ter should be considered [12].
• Patients having USM should be on regular follow-up
with surveillance colonoscopy annually. And if they showPage 2 of 4
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other forms of diversion [13].
• Obstructive urinary symptoms, bleeding per rectum
and/or change in bowel habits after USM should be taken
seriously and promptly investigated by colonoscopy and
CT-scan.
• If USM is converted to other forms of diversion, the site
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